Skip to main content

NeuBase Therapeutics, Inc.

NBSEDelisted May 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001173281

NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in NeuBase Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
−1 vs. Q4 2021
Shares held
12.4M
+1.13M (+10.1%) vs. Q4 2021
Total value
$23.3M
−$8.32M (−26.4%) vs. Q4 2021
New holders
6
8 more added
Sold out
7
12 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NBSE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 45 institutions
Q1 2021: 57 institutionsQ2 2021: 59 institutionsQ3 2021: 48 institutionsQ4 2021: 46 institutionsQ1 2022: 45 institutionsQ2 2022: 43 institutionsQ3 2022: 44 institutionsQ4 2022: 35 institutionsQ1 2023: 36 institutionsQ2 2023: 26 institutionsQ3 2023: 20 institutionsQ4 2023: 21 institutionsQ1 2024: 18 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $23.3M
Q1 2021: $59.4MQ2 2021: $51.5MQ3 2021: $36.6MQ4 2021: $31.6MQ1 2022: $23.3MQ2 2022: $13.4MQ3 2022: $4.74MQ4 2022: $1.94MQ1 2023: $1.72MQ2 2023: $1.08MQ3 2023: $301.2KQ4 2023: $340.2KQ1 2024: $177.1KQ2 2024: $4.95KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NBSE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$4.95K
Q1 202418$177.1K
Q4 202321$340.2K
Q3 202320$301.2K
Q2 202326$1.08M
Q1 202336$1.72M
Q4 202235$1.94M
Q3 202244$4.74M
Q2 202243$13.4M
Q1 202245$23.3M
Q4 202146$31.6M
Q3 202148$36.6M
Q2 202159$51.5M
Q1 202157$59.4M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding NeuBase Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding NBSE in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Greenlight Capital Inc2,727,027$5.13M0.33%00.0%Unchanged
Point72 Asset Management, L.P.1,250,000$2.35M0.01%00.0%Unchanged
Vanguard Group Inc1,059,054$1.99M0.00%−305,580−22.4%Reduced
AIGH Capital Management LLC1,027,585$1.93M0.70%+27,300+2.7%Added
Decheng Capital Management III (Cayman), LLC1,000,000$1.88M0.58%+1,000,000New
Carnegie Mellon University939,412$1.77M0.74%00.0%Unchanged
Sio Capital Management, LLC906,445$1.70M0.69%00.0%Unchanged
Polar Asset Management Partners Inc.634,618$1.19M0.01%00.0%Unchanged
Jacob Asset Management of New York LLC426,424$802.0K0.49%00.0%Unchanged
CM Management, LLC325,000$611.0K0.51%+175,000+116.7%Added
Prelude Capital Management, LLC311,000$585.0K0.03%00.0%Unchanged
Worth Venture Partners, LLC256,553$482.0K0.23%+27,300+11.9%Added
Geode Capital Management, LLC243,984$458.0K0.00%00.0%Unchanged
Renaissance Technologies LLC214,838$404.0K0.00%+92,452+75.5%Added
Royal Bank of Canada114,473$215.0K0.00%+44,791+64.3%Added
Deutsche Bank AG100,000$188.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp87,210$164.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc82,199$155.0K0.00%−192−0.2%Reduced
Waldron Private Wealth LLC79,620$149.0K0.01%+59,532+296.4%Added
BlackRock Inc.75,425$141.0K0.00%−3,087−3.9%Reduced
State Street Corp68,687$129.0K0.00%+10,674+18.4%Added
Perkins Capital Management Inc66,500$125.0K0.10%+36,500+121.7%Added
Northern Trust Corp54,926$103.0K0.00%00.0%Unchanged
Tocqueville Asset Management L.P.53,500$101.0K0.00%00.0%Unchanged
Davenport & Co LLC45,500$86.0K0.00%−3,000−6.2%Reduced
D. E. Shaw & Co., Inc.37,416$70.0K0.00%+37,416New
Two Sigma Advisers, LP25,350$48.0K0.00%−14,740−36.8%Reduced
Wealthsource Partners, LLC23,850$45.0K0.00%+23,850New
Susquehanna International Group, LLP18,339$34.0K0.00%−15,193−45.3%Reduced
Millennium Management LLC17,375$33.0K0.00%−9,877−36.2%Reduced
Bank of America Corp16,103$31.0K0.00%−359−2.2%Reduced
Oppenheimer & Co Inc15,750$30.0K0.00%00.0%Unchanged
First Manhattan Co14,124$26.0K0.00%+14,124New
Tower Research Capital LLC (TRC)12,072$23.0K0.00%−7,873−39.5%Reduced
Knightsbridge Asset Management, LLC10,523$20.0K0.01%+10,523New
Heritage Wealth Advisors10,000$19.0K0.00%00.0%Unchanged
Two Sigma Investments, LP10,222$19.0K0.00%+10,222New
Simplex Trading, LLC5,316$9.00K0.00%−3,008−36.1%Reduced
Cubist Systematic Strategies, LLC2,525$5.00K0.00%−3,792−60.0%Reduced
Morgan Stanley1,029$2.00K0.00%−8,388−89.1%Reduced
The PNC Financial Services Group, Inc.427$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.450$1.00K0.00%00.0%Unchanged
Wells Fargo & Company190$00.00%00.0%Unchanged
Global Wealth Management Investment Advisory, Inc.250$00.00%00.0%Unchanged
Newbridge Financial Services Group, Inc.250$00.00%00.0%Unchanged
Citadel Advisors LLC0$00.00%−29,528−100.0%Sold out
Fifth Lane Capital, LP0$00.00%−20,000−100.0%Sold out
UBS Group AG0$00.00%−7,436−100.0%Sold out
Optiver Holding B.V.0$00.00%−3,210−100.0%Sold out
Eaton Vance Management0$00.00%−750−100.0%Sold out
Ancora Advisors, LLC0$00.00%−100−100.0%Sold out
Ritter Daniher Financial Advisory, LLC0$00.00%−2−100.0%Sold out